BillionToOne, Inc. (BLLN)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	n/a
Revenue (ttm)	209.03M
Net Income (ttm)	-30.62M
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About BLLN

BillionToOne is transforming healthcare by redefining molecular diagnostics. Our revolutionary single molecule NGS (smNGS) platform achieves what was once thought impossible – detecting and precisely quantifying genetic targets with single-molecule sensitivity. Our superior technology platform has enabled us to build category-defining prenatal and oncology products. Our products reveal actionable insights from a simple blood draw that are fundamentally changing how diseases are diagnosed and treated, leading to a paradigm shift in personalized ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2016
• Employees: 620
• Stock Exchange: NASDAQ
• Ticker Symbol: BLLN
• Website: https://www.billiontoone.com/

Financial Performance

Financial numbers in USD